BE1001204A5 - Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments. - Google Patents
Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments. Download PDFInfo
- Publication number
- BE1001204A5 BE1001204A5 BE8801044A BE8801044A BE1001204A5 BE 1001204 A5 BE1001204 A5 BE 1001204A5 BE 8801044 A BE8801044 A BE 8801044A BE 8801044 A BE8801044 A BE 8801044A BE 1001204 A5 BE1001204 A5 BE 1001204A5
- Authority
- BE
- Belgium
- Prior art keywords
- pharmaceutical composition
- water
- cyclosporine
- composition according
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3730909 | 1987-09-15 | ||
| DE3802355 | 1988-01-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE1001204A5 true BE1001204A5 (fr) | 1989-08-16 |
Family
ID=25859774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE8801044A BE1001204A5 (fr) | 1987-09-15 | 1988-09-12 | Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments. |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JP3090666B2 (fi) |
| KR (1) | KR0131084B1 (fi) |
| AT (1) | AT395819B (fi) |
| AU (1) | AU628787B2 (fi) |
| BE (1) | BE1001204A5 (fi) |
| CA (1) | CA1338775C (fi) |
| CH (1) | CH683672A5 (fi) |
| DK (1) | DK175132B1 (fi) |
| ES (1) | ES2012118A6 (fi) |
| FI (1) | FI94837C (fi) |
| FR (1) | FR2620336B1 (fi) |
| GB (1) | GB2209671B (fi) |
| GR (1) | GR1002243B (fi) |
| HU (1) | HU205010B (fi) |
| IE (1) | IE61195B1 (fi) |
| IL (1) | IL87746A (fi) |
| IT (1) | IT1224886B (fi) |
| LU (1) | LU87335A1 (fi) |
| MY (1) | MY103769A (fi) |
| NL (1) | NL195094C (fi) |
| NO (1) | NO179434C (fi) |
| NZ (1) | NZ226163A (fi) |
| PT (1) | PT88492B (fi) |
| SE (1) | SE503279C2 (fi) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6007840A (en) * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
| GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| GR1000466B (el) * | 1989-01-28 | 1992-07-30 | Sandoz Ag | Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης. |
| BE1003009A5 (fr) * | 1989-02-09 | 1991-10-22 | Sandoz Sa | Nouvelles compositions pharmaceutiques a base de cyclosporines. |
| GB8916901D0 (en) | 1989-07-24 | 1989-09-06 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
| ATE147619T1 (de) | 1992-05-13 | 1997-02-15 | Sandoz Ag | Opthalmische zusammensetzungen enthaltend ein cyclosporin |
| ES2168271T3 (es) | 1992-09-25 | 2002-06-16 | Novartis Ag | Composiciones farmaceuticas que contienen ciclosporinas. |
| SI1033128T2 (sl) * | 1993-09-28 | 2012-02-29 | Scherer Gmbh R P | Izdelava mehke Ĺľelatinaste kapsule |
| ATE218359T1 (de) | 1994-11-03 | 2002-06-15 | Novartis Erfind Verwalt Gmbh | Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung |
| US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
| US5766629A (en) | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
| US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| DE19549852B4 (de) | 1995-11-29 | 2009-06-04 | Novartis Ag | Cyclosporin enthaltende Präparate |
| TW414696B (en) * | 1996-07-01 | 2000-12-11 | Mitsubishi Kagaku Foods Kk | Anti-bacteria agent |
| TR199901686T2 (xx) | 1997-01-30 | 1999-09-21 | Norvartis Ag | Esasen ya�s�z farmakolojik kompozisyonlar� i�eren sert jelatin kaps�ller. |
| GB2326337A (en) * | 1997-06-20 | 1998-12-23 | Phares Pharma Holland | Homogeneous lipid compositions for drug delivery |
| US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
| EP1558215A4 (en) * | 2003-10-14 | 2007-09-12 | Wockhardt Ltd | STERILE GELIFYING AGENTS |
| JP5422871B2 (ja) * | 2006-10-24 | 2014-02-19 | 不二製油株式会社 | イソフラボン類組成物 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5986M (fi) * | 1966-11-22 | 1968-06-21 | ||
| DE1617557A1 (de) * | 1966-05-12 | 1971-04-01 | Suga Kazuo | Stabile Oryzanolloesung und Verfahren zur Herstellung derselben |
| DE2241667B2 (de) * | 1971-08-25 | 1974-09-19 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | Stabiles pharmazeutisches Mittel in Form einer wässrigen oralen anwendbaren Suspension |
| FR2381520A1 (fr) * | 1977-02-28 | 1978-09-22 | Yamanouchi Pharma Co Ltd | Compositions pour usage rectal |
| GB2015339A (en) * | 1978-03-07 | 1979-09-12 | Sandoz Ltd | Compositions comprising mono-cyclic peptides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE624258A (fi) * | 1961-10-31 | |||
| JPS57128634A (en) * | 1981-02-03 | 1982-08-10 | Eisai Co Ltd | Elastase-containing compound increasing absorption |
| EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
| JPS61280435A (ja) * | 1985-04-04 | 1986-12-11 | Kanji Takada | サイクロスポリン類のリンパ指向性製剤 |
-
1988
- 1988-09-01 HU HU884518A patent/HU205010B/hu unknown
- 1988-09-12 CH CH3398/88A patent/CH683672A5/de not_active IP Right Cessation
- 1988-09-12 LU LU87335A patent/LU87335A1/xx unknown
- 1988-09-12 FR FR888811953A patent/FR2620336B1/fr not_active Expired - Lifetime
- 1988-09-12 BE BE8801044A patent/BE1001204A5/fr not_active IP Right Cessation
- 1988-09-13 AU AU22172/88A patent/AU628787B2/en not_active Expired
- 1988-09-13 NZ NZ226163A patent/NZ226163A/xx unknown
- 1988-09-13 PT PT88492A patent/PT88492B/pt not_active IP Right Cessation
- 1988-09-13 GB GB8821443A patent/GB2209671B/en not_active Expired - Lifetime
- 1988-09-13 SE SE8803221A patent/SE503279C2/sv not_active IP Right Cessation
- 1988-09-13 IE IE277288A patent/IE61195B1/en not_active IP Right Cessation
- 1988-09-13 FI FI884192A patent/FI94837C/fi not_active IP Right Cessation
- 1988-09-13 NO NO884052A patent/NO179434C/no not_active IP Right Cessation
- 1988-09-13 CA CA000577214A patent/CA1338775C/en not_active Expired - Lifetime
- 1988-09-14 MY MYPI88001027A patent/MY103769A/en unknown
- 1988-09-14 JP JP63231396A patent/JP3090666B2/ja not_active Expired - Lifetime
- 1988-09-14 GR GR880100602A patent/GR1002243B/el not_active IP Right Cessation
- 1988-09-14 IT IT8848349A patent/IT1224886B/it active
- 1988-09-14 KR KR1019880011874A patent/KR0131084B1/ko not_active IP Right Cessation
- 1988-09-14 AT AT0224988A patent/AT395819B/de not_active IP Right Cessation
- 1988-09-14 IL IL87746A patent/IL87746A/xx active Protection Beyond IP Right Term
- 1988-09-14 DK DK198805111A patent/DK175132B1/da not_active IP Right Cessation
- 1988-09-15 NL NL8802275A patent/NL195094C/nl not_active IP Right Cessation
- 1988-09-15 ES ES8802831A patent/ES2012118A6/es not_active Expired - Lifetime
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1617557A1 (de) * | 1966-05-12 | 1971-04-01 | Suga Kazuo | Stabile Oryzanolloesung und Verfahren zur Herstellung derselben |
| FR5986M (fi) * | 1966-11-22 | 1968-06-21 | ||
| DE2241667B2 (de) * | 1971-08-25 | 1974-09-19 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | Stabiles pharmazeutisches Mittel in Form einer wässrigen oralen anwendbaren Suspension |
| FR2381520A1 (fr) * | 1977-02-28 | 1978-09-22 | Yamanouchi Pharma Co Ltd | Compositions pour usage rectal |
| GB2015339A (en) * | 1978-03-07 | 1979-09-12 | Sandoz Ltd | Compositions comprising mono-cyclic peptides |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1001204A5 (fr) | Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments. | |
| US5756450A (en) | Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms | |
| BE1005236A3 (fr) | Compositions pharmaceutiques a base de cyclosporines. | |
| BE1010112A4 (fr) | Compositions pharmaceutiques. | |
| JP4073503B2 (ja) | サイクロスポリンを含有する液体製剤とその調製方法 | |
| EP0593656B1 (fr) | Nouvelles compositions a base de derives de la classe des taxanes | |
| US5407683A (en) | Pharmaceutical solutions and emulsions containing taxol | |
| FR2642650A1 (fr) | Nouvelles compositions pharmaceutiques a base de cyclosporines | |
| FI89065C (fi) | Foerfarande foer framstaellning av en ny siklosporin kristallform | |
| JP2003534265A (ja) | 生物学的に活性な親水性化合物を非経口的に投与するための徐放性薬剤組成物 | |
| JPH10508306A (ja) | 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法 | |
| FR2636534A1 (fr) | Compositions pharmaceutiques a base de cyclosporines | |
| HU201567B (en) | Process for production of intravenous medical compositions containing cyclosphorin | |
| LU86901A1 (fr) | Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale | |
| EP1377316A1 (fr) | Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie | |
| JP3917820B2 (ja) | オザグレルナトリウム含有注射液およびその安定化方法 | |
| DE3830494B4 (de) | Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe | |
| KR0173349B1 (ko) | 사이클로스포린-함유 고체 분산체 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE20 | Patent expired |
Owner name: *NOVARTIS A.G. Effective date: 20080912 |